Cargando…
Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644612/ https://www.ncbi.nlm.nih.gov/pubmed/37964376 http://dx.doi.org/10.1186/s13063-023-07659-5 |
| _version_ | 1785147266177171456 |
|---|---|
| author | Molina-Morant, D. Fernández, M. L. Bosch-Nicolau, P. Sulleiro, E. Bangher, M. Salvador, F. Sanchez-Montalva, A. Ribeiro, A. L. P. de Paula, A. M. B. Eloi, S. Correa-Oliveira, R. Villar, J. C. Sosa-Estani, S. Molina, I. |
| author_facet | Molina-Morant, D. Fernández, M. L. Bosch-Nicolau, P. Sulleiro, E. Bangher, M. Salvador, F. Sanchez-Montalva, A. Ribeiro, A. L. P. de Paula, A. M. B. Eloi, S. Correa-Oliveira, R. Villar, J. C. Sosa-Estani, S. Molina, I. |
| author_sort | Molina-Morant, D. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10644612 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106446122023-11-14 Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial Molina-Morant, D. Fernández, M. L. Bosch-Nicolau, P. Sulleiro, E. Bangher, M. Salvador, F. Sanchez-Montalva, A. Ribeiro, A. L. P. de Paula, A. M. B. Eloi, S. Correa-Oliveira, R. Villar, J. C. Sosa-Estani, S. Molina, I. Trials Correction BioMed Central 2023-11-14 /pmc/articles/PMC10644612/ /pubmed/37964376 http://dx.doi.org/10.1186/s13063-023-07659-5 Text en © The Author(s). 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Molina-Morant, D. Fernández, M. L. Bosch-Nicolau, P. Sulleiro, E. Bangher, M. Salvador, F. Sanchez-Montalva, A. Ribeiro, A. L. P. de Paula, A. M. B. Eloi, S. Correa-Oliveira, R. Villar, J. C. Sosa-Estani, S. Molina, I. Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial |
| title | Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial |
| title_full | Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial |
| title_fullStr | Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial |
| title_full_unstemmed | Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial |
| title_short | Correction: Efficacy and safety assessment of different dosage of benznidazol for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial |
| title_sort | correction: efficacy and safety assessment of different dosage of benznidazol for the treatment of chagas disease in chronic phase in adults (multibenz study): study protocol for a multicenter randomized phase ii non-inferiority clinical trial |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644612/ https://www.ncbi.nlm.nih.gov/pubmed/37964376 http://dx.doi.org/10.1186/s13063-023-07659-5 |
| work_keys_str_mv | AT molinamorantd correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT fernandezml correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT boschnicolaup correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT sulleiroe correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT bangherm correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT salvadorf correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT sanchezmontalvaa correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT ribeiroalp correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT depaulaamb correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT elois correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT correaoliveirar correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT villarjc correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT sosaestanis correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial AT molinai correctionefficacyandsafetyassessmentofdifferentdosageofbenznidazolforthetreatmentofchagasdiseaseinchronicphaseinadultsmultibenzstudystudyprotocolforamulticenterrandomizedphaseiinoninferiorityclinicaltrial |